Abstract
The number of people affected by HIV is bound to increase all over the world, including Asia. This will require an additional effort to cope with the needs of those infected Provision of care and support to people living with HIV/AIDS and to their families will become crucial in decreasing the burden on families and on communities, and consequently on the most affected countries. Provision of care will progressively include the use of antiretrovirals even in resource-limited settings, with support provided by local political commitment and by donors. Therefore, it is necessary that these drugs be properly and rationally used. In this regard the WHO—at all levels— continues to advocate for a larger access toAR Vs and to provide the necessary support to member countries for implementing HIV/AIDS care programmes that include the use of antiretrovirals.
| Centres for Disease Control and Prevention ( 1998). Report of the NIH panel to define principles of therapy of HIV infection. Morbidity and Mortality Weekly Report, 47 (RR-5),1-41. Google Scholar, Paige Promotion Promotion Paige qavO7O | |
| Gebo, K.A., R.E. Chaisson, J.G. Folkemer, J.G. Bartlett and R.D. Moore (1999). Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS, 13(8), 963-69. Google Scholar, Crossref, Medline | |
| Hogg, R.S. et al. (2001). Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. Journal of the American MedicalAssociation, 286(20), 2568-77. Google Scholar, Crossref, Medline | |
| Jordan, R.G.L., C. Cummins and C. Hyde (2002). Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. British Medical Journal, 324(7340), 757-60. Google Scholar, Crossref, Medline | |
| Matthews, G.V. et al. (2002). Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: A cohort study. AIDS, 16(1), 53-61. Google Scholar, Crossref, Medline | |
| Narain, J.P., C. Chela and E. van Praag (Promotion Promotion Maurices Promotion Maurices Promotion Maurices Maurices Promotion Maurices 2000). Planning and implementing HIV/AIDS care programmes: A step-by-step approach. SEA/AIDS/106, WHO, New Delhi. Google Scholar | |
| Perelson, A.S., A.U. Neumann, M. Markowitz, J.M. Leonard and D.D. Ho (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science , 271(5255),1582-86. Google Scholar, Crossref, Medline | |
| Piot, P. and A.M. Coll Seck (2001). International response to the HIV/AIDS epidemic: Planning for success. Bulletin of the World Health Organization , 79(2),1106-12. Google Scholar, Medline | |
| Sterling, T.R., R.E. Chaisson and R.D. Moore (2001). HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS, 15, 2251-57. Google Scholar, Crossref, Medline | |
| Who-Searo (2002). The use of antiretroviral therapy: A simplified approach for resource-constrained countries . WHO Regional Office for South-East Asia, SEA/AIDS/ 133. Google Scholar | |
| Who (2002a). Scaling up antiretroviral therapy in resource-limited settings: Guidelines for a public health approach , WHO, WHO/HIV/2002.02. Google Scholar | |
| — ( 2002b). WHO list of pre-qualified products. Available at http://www.who.int/medicines/organization/qsm/activities/pilotproc/pilotproc.shtml . Google Scholar | |
| — ( 2002c). WHO model list of essential medicines. Available at http://www.who.int/medicines/organization/par/edl/expertcomm.shtml . Google Scholar |